Table 3.
Treatment | ClinicalTrials.gov ID |
---|---|
MORAb-009 (anti-mesothelin) | NCT01018784, NCT00711191 |
Trastuzumab (anti-Her2/neu) | NCT00003797 |
Cetuximab (anti-EGFR) | NCT00923299, NCT00042939, NCT00448838, NCT00305760, NCT00075686, NCT00408564, NCT00467116 |
Panitumumab (anti-EGFR) | NCT00004879, NCT00601627, NCT00550836 |
Nimotuzumab (anti-EGFR) | NCT00561990 |
Trastuzumab and cetuximab | NCT00599833 |
EGFR: EGF-receptor.